Navigation Links
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
Date:11/5/2009

AURORA, Ontario, Nov. 5 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced today that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial.

The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden. Patients participating in the trial self-administer active treatment or control cream to the external ano-genital region twice-daily, for five consecutive days per week over a treatment period of eight weeks, with a follow-up visit at 16 weeks. Only female subjects were enrolled in the trial in order to avoid inter-sex treatment variations. The trial was designed to enroll 120 patients, whereby half were intended to receive Topical Interferon Alpha-2b and the other half a vehicle cream intended to serve as a placebo control. The primary endpoint for the trial will be comparison of the proportion of patients with complete clearance of their baseline lesions during the eight week treatment period.

"This is an important milestone for Helix's Topical Interferon Alpha-2b clinical program," said John Docherty, president and COO of Helix BioPharma. "Our efforts to enhance the recruitment rate over recent months have been successful, and we now look forward to obtaining the results of this trial once all patient procedures and analyses are completed."

Moving forward, based on the trial design and schedule, Helix expects patients to complete all study procedures by the early part of calendar 2010, followed thereafter by closing of the database, analysis of the results and final reporting in mid to late calendar 2010.

About Ano-Genital Warts

Ano-genital warts result from HPV infection of the external genitalia, and can manifest as outwardly visible growths of varying sizes and s
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Helix BioPharma Corp. Announces Fiscal 2009 Results
2. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
3. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
4. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
5. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
6. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
10. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
11. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... -- ,, Reportlinker.com announces that a new ma.... ,, Global Markets for Breast Biopsy Devices .../Global-Markets-for-Breast-Biopsy-Devices-2009.htm...campaign=prnewswire ,, The global markets for...core needle market and vacuum assisted breast biop...
(Date:11/20/2009)... Boston Scientific Corpo...received 510(k) clearance from the U.S. Food and D...arket its WallFlex® Fully Covered Esophageal ...rictures (obstructions) caused by tumors in patien...ncer. ,, (Photo: http://www.newscom.com/cgi-...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- In response to a recent ...tly available medications designed to treat and pr...te, an independent nonprofit organization, is offe... Prevention of Prostate Cancer for free download...rticle, " Drugs to Deter Some Cancers Are Not Take...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3CMHS 28dba Hybrid Energy Holdings 29 changes name of corporation and prepares to file for ticker symbol change with FINRA 58135 1CMHS 28dba Hybrid Energy Holdings 29 changes name of corporation and prepares to file for ticker symbol change with FINRA 58135 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 1Bubble Trouble Team Hits the Lab for Good Hygiene 58133 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 4MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 1MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 2
...irstCall/ -- Auxilium,Pharmaceuticals, Inc. today ...oms of decreased libido, energy levels and,erectil...switching,brands of testosterone replacement gel t...icantly in patients who switched to,Auxilium,s Tes...response to Solvay S.A.,s Androgel(R) (testosteron...
...College of Cardiology,s,Board of Trustees has appr....C., arising from his statements that resulted in ... embargo on the,COURAGE trial data presented at Am...cientific Session in March. ,The Board accepted th...pline Committee to issue a letter of censure to an...
Other Medicine Technology:Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
(Date:11/20/2009)...., Nov. 20 Rates of infe...aked in late October, but the pandemic flu virus c...l age groups, including the elderly, according to ...SE: DGX ), the world,s leading provider of diagn... its most recent Quest Diagnostics Health Trends(T...
(Date:11/20/2009)...20 The following is a s...he Nevada Health Care Association: ,, "The Neva...nks Senate Majority Leader Harry Reid for his lead...ur goal of protecting every Nevada seniors, ongoin...ing the strength and viability of our state,s vita...
(Date:11/20/2009)...vember 20, 2009Emergency medical service (EMS) pro...0,000 cardiac arrests each year. Only 5 to 10 per...ive. Better quality cardiopulmonary resuscitation...e associated with better patient outcome. The Res...t clinical research network to study prehospital t...
(Date:11/20/2009)...high and is expected to continue, CDC says, , ...areas of the United States are seeing declines in ... said Friday, and while the disease remains widesp...reported last week. , "We are beginning to see ...ntry, but there is still a lot of influenza everyw...
(Date:11/20/2009)... ANGELES, Nov. 20 California minor...ican Families, The Wall/Las Memorias, Latina Breas...Program, and the Real Medicine Foundation today se...n the company to reconsider harmful and discrimina...hield specifically calls for an end to the practic...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4
...tage of services in a hospital at Brisbane a patie...y. Although he was attacked and was in serious con...al in question is // the Caboolture Hospital, wher... day. The statement by a spokesman for the Que...
... largest drug maker, Pfizer has announced that it ...in India. Exubera received regulatory approvals fr... European Commission last week. The drug has been ...syringes are needed. "Until today, patients with d...
..., a Crohn’s patient has successfully reached the V...ountains. The climb began // on January 12th and w...ght days of unpredictable and sub-freezing tempera...ost 80 pounds and his large intestine through an o...
...reet Journal studied about the effects of stress o...ber of researches is being conducted on stress and... There is an increase in the number of pregnant...ement of stress during pregnancy. Women es...
...rds in Cyprus are reported to be infected with the...the virus in a European Union country, even though...ts of the island. // Northern Cyprus where the inf...asualties in Turkey. Animal products imports from ...
... certification has been received by the global hea...cting the Neissera gonorrhoeae (NG) and Chlamydia .... This will enable the company to sell the product...article technology. Where sexually transmit...
Other Medicine News:Health News:Crohn's Patient Robert Hill’s greatest achievemen 2
... Roches patented polymerase chain reaction (PCR) t...cation technology, is an essential component of Ro...roducts. PCR allows minute amounts of selected uni...to billions of copies (that is, to detectable leve...
BenchMark® XT
... Reicherts new ATP Auto Non-Contact Tonometer / Pa... pachymeter, combining the measurement of IOP and ...e to numerous clinical studies that have shown the... as well as intraocular pressure in the management...
... Argent Global Services is a process engineering a...development and implementation of productivity imp...tegies. Argent utilizes industrial engineering, le... significant and cost effective solutions that dri...
Medicine Products: